565 related articles for article (PubMed ID: 9554282)
1. Development of an animal model to assess the immunogenicity of single-dose tetanus and diphtheria vaccines based on controlled release from biodegradable polymer microspheres.
Gupta RK; Griffin P; Rivera R; Siber GR
Dev Biol Stand; 1998; 92():277-87. PubMed ID: 9554282
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a guinea pig model to assess interference in the immunogenicity of different components of a combination vaccine comprising diphtheria, tetanus and acellular pertussis (DTaP) vaccine and haemophilus influenzae type b capsular polysaccharide conjugate vaccine.
Gupta RK; Anderson R; Cecchini D; Rost B; Xu J; Gendreau K; Saroff DL; Marchant C; Siber GR
Biologicals; 1999 Jun; 27(2):167-76. PubMed ID: 10600208
[TBL] [Abstract][Full Text] [Related]
3. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
[TBL] [Abstract][Full Text] [Related]
4. Comparison of adjuvant activities of aluminium phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid.
Gupta RK; Siber GR
Biologicals; 1994 Mar; 22(1):53-63. PubMed ID: 8068314
[TBL] [Abstract][Full Text] [Related]
5. Chronic local tissue reactions, long-term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers.
Gupta RK; Alroy J; Alonso MJ; Langer R; Siber GR
Vaccine; 1997 Nov; 15(16):1716-23. PubMed ID: 9364673
[TBL] [Abstract][Full Text] [Related]
6. In vivo distribution of radioactivity in mice after injection of biodegradable polymer microspheres containing 14C-labeled tetanus toxoid.
Gupta RK; Chang AC; Griffin P; Rivera R; Siber GR
Vaccine; 1996 Oct; 14(15):1412-6. PubMed ID: 8994315
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems.
Gupta RK; Chang AC; Siber GR
Dev Biol Stand; 1998; 92():63-78. PubMed ID: 9554260
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the immune response to tetanus toxoid by polylactide-polyglycolide microspheres.
Walker KB; Xing DK; Sesardic D; Corbel MJ
Dev Biol Stand; 1998; 92():259-67. PubMed ID: 9554281
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses.
Halperin SA; King J; Law B; Mills E; Willems P
Clin Infect Dis; 1999 May; 28(5):995-1001. PubMed ID: 10452624
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin E responses to diphtheria and tetanus toxoids after booster with aluminium-adsorbed and fluid DT-vaccines.
Mark A; Björkstén B; Granström M
Vaccine; 1995 May; 13(7):669-73. PubMed ID: 7668036
[TBL] [Abstract][Full Text] [Related]
11. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
Gupta RK; Siber GR
Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
[TBL] [Abstract][Full Text] [Related]
12. Estimation of antigenic tetanus toxoid extracted from biodegradable microspheres.
Xing DK; McLellan K; Corbel MJ; Sesardic D
Biologicals; 1996 Mar; 24(1):57-65. PubMed ID: 8733602
[TBL] [Abstract][Full Text] [Related]
13. Studies on the adequate composition of diphtheria and tetanus toxoids-with reference to the amounts of toxoids and aluminum adjuvant.
Someya S; Mizuhara H; Murata R; Kurokawa M
Jpn J Med Sci Biol; 1981 Feb; 34(1):21-35. PubMed ID: 7265558
[TBL] [Abstract][Full Text] [Related]
14. Single dose vaccine based on biodegradable polyanhydride microspheres can modulate immune response mechanism.
Kipper MJ; Wilson JH; Wannemuehler MJ; Narasimhan B
J Biomed Mater Res A; 2006 Mar; 76(4):798-810. PubMed ID: 16345084
[TBL] [Abstract][Full Text] [Related]
15. Strategies for stabilising tetanus toxoid towards the development of a single-dose tetanus vaccine.
Schwendeman SP; Costantino HR; Gupta RK; Tobio M; Chang AC; Alonso MJ; Siber GR; Langer R
Dev Biol Stand; 1996; 87():293-306. PubMed ID: 8854030
[TBL] [Abstract][Full Text] [Related]
16. Models for assessing the effect of toxicants on immunocompetence in mice. II. Effect of cyclophosphamide on the antibody responses to type III pneumococcal polysaccharide and tetanus toxoid in BALB/c female mice.
Speirs RS; Benson RW; Knowles BJ; Roberts D
J Environ Pathol Toxicol; 1978; 1(6):791-812. PubMed ID: 32218
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a diphtheria and tetanus PLGA microencapsulated vaccine formulation without stabilizers.
Quintilio W; Takata CS; Sant'Anna OA; da Costa MH; Raw I
Curr Drug Deliv; 2009 Jul; 6(3):297-04. PubMed ID: 19604144
[TBL] [Abstract][Full Text] [Related]
18. [Long-term immunogenicity and immunologic priming of animals to pulsed controlled-release system for tetanus toxoid vaccine delivery].
He Y; Chen ZH; Wei SL
Yao Xue Xue Bao; 2001 Sep; 36(9):695-8. PubMed ID: 12580111
[TBL] [Abstract][Full Text] [Related]
19. An antibody induction method in mice for the potency assays of diphtheria and tetanus components in combined vaccines.
Maheshwari SC; Sharma SB; Kumar A; Sokhey J
J Commun Dis; 1998 Sep; 30(3):139-46. PubMed ID: 10093418
[TBL] [Abstract][Full Text] [Related]
20. Stimulating role of toxoids-laden liposomes in oral immunization against diphtheria and tetanus infections.
Mirchamsy H; Manhouri H; Hamedi M; Ahourai P; Fateh G; Hamzeloo Z
Biologicals; 1996 Dec; 24(4):343-50. PubMed ID: 9088551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
